Geron (GERN) Non-Current Assets (2010 - 2026)
Geron's (GERN) quarterly Non-Current Assets came in at $35.6 million in Q1 2026, down 46.63% year-on-year from $66.7 million in Q1 2025, and down 29.2% quarter-over-quarter from $50.3 million in Q4 2025.
Geron (GERN) Non-Current Assets (2010 - 2026) Analysis & Trends
Geron has disclosed Non-Current Assets across 17 years of filings, most recently posting $35.6 million for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $35.6 million, down 46.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $180.5 million (down 38.28% YoY), and the FY2025 annual result was $50.3 million, down 51.09% from the prior year.
- Non-Current Assets came in at $35.6 million for Q1 2026 at Geron, down from $50.3 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $102.8 million in Q4 2024 to a low of $10.3 million in Q4 2022.
- The 5-year median for Non-Current Assets is $45.0 million (2025), against an average of $45.0 million.
- Across the five-year window, Non-Current Assets tumbled 78.82% in 2022 and soared 639.67% in 2023, its largest moves.
- Geron's Non-Current Assets stood at $10.3 million in 2022, then surged by 410.49% to $52.7 million in 2023, then surged by 94.94% to $102.8 million in 2024, then slumped by 51.09% to $50.3 million in 2025, then fell by 29.2% to $35.6 million in 2026.
- The last three Non-Current Assets figures came in at $35.6 million (Q1 2026), $50.3 million (Q4 2025), and $45.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 39.71 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 35.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.59 Mn |
| Dec 31, 2025 | 50.27 Mn |
| Sep 30, 2025 | 45.04 Mn |
| Jun 30, 2025 | 49.60 Mn |
| Mar 31, 2025 | 66.68 Mn |
| Dec 31, 2024 | 102.79 Mn |
| Sep 30, 2024 | 46.89 Mn |
| Jun 30, 2024 | 76.09 Mn |
| Mar 31, 2024 | 30.57 Mn |
| Dec 31, 2023 | 52.73 Mn |
| Sep 30, 2023 | 77.93 Mn |
| Jun 30, 2023 | 38.02 Mn |
| Mar 31, 2023 | 37.85 Mn |
| Dec 31, 2022 | 10.33 Mn |
| Sep 30, 2022 | 10.54 Mn |
| Jun 30, 2022 | 10.79 Mn |
| Mar 31, 2022 | 22.50 Mn |
| Dec 31, 2021 | 38.83 Mn |
| Sep 30, 2021 | 49.74 Mn |
| Jun 30, 2021 | 50.41 Mn |